| 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) E Arbelo, A Protonotarios, JR Gimeno, E Arbustini, R Barriales-Villa, ... European heart journal 44 (37), 3503-3626, 2023 | 880 | 2023 |
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 862 | 2020 |
| Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies MF Ortiz-Genga, S Cuenca, M Dal Ferro, E Zorio, R Salgado-Aranda, ... Journal of the American College of Cardiology 68 (22), 2440-2451, 2016 | 460 | 2016 |
| Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week M Pieroni, JC Moon, E Arbustini, R Barriales-Villa, A Camporeale, ... Journal of the American College of Cardiology 77 (7), 922-936, 2021 | 230 | 2021 |
| Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids) G Norrish, T Ding, E Field, L Ziółkowska, I Olivotto, G Limongelli, ... JAMA cardiology 4 (9), 918-927, 2019 | 191 | 2019 |
| Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy MS Maron, A Masri, L Choudhury, I Olivotto, S Saberi, A Wang, ... Journal of the American College of Cardiology 81 (1), 34-45, 2023 | 133 | 2023 |
| Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene MM Akhtar, M Lorenzini, M Cicerchia, JP Ochoa, TM Hey, ... Circulation: Heart Failure 13 (10), e006832, 2020 | 130 | 2020 |
| Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations F Domínguez, S Cuenca, Z Bilińska, R Toro, E Villard, R Barriales-Villa, ... Journal of the American College of Cardiology 72 (20), 2471-2481, 2018 | 130 | 2018 |
| Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy L Escobar-Lopez, JP Ochoa, JG Mirelis, MÁ Espinosa, M Navarro, ... Journal of the American College of Cardiology 78 (17), 1682-1699, 2021 | 110 | 2021 |
| Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy JP Ochoa, M Sabater-Molina, JM García-Pinilla, J Mogensen, ... Journal of the American College of Cardiology 72 (20), 2457-2467, 2018 | 86 | 2018 |
| Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain D García-Giustiniani, M Arad, M Ortíz-Genga, R Barriales-Villa, ... Heart 101 (13), 1047-1053, 2015 | 85 | 2015 |
| Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis A Lopez-Sainz, F Dominguez, LR Lopes, JP Ochoa, R Barriales-Villa, ... Journal of the American College of Cardiology 76 (2), 186-197, 2020 | 79 | 2020 |
| Adult congenital anomalies of the coronary arteries described over 31 years of angiographic studies in the Asturias Principality: main angiographic and clinical characteristics RB Villa, C Moris, AL Muñiz, LC Hernandez, L San Roman, VB Alvarez, ... Revista espanola de cardiologia 54 (3), 269-281, 2001 | 74 | 2001 |
| An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease DP Germain, G Altarescu, R Barriales-Villa, R Mignani, K Pawlaczyk, ... Molecular genetics and metabolism 137 (1-2), 49-61, 2022 | 69 | 2022 |
| Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease M Sabater Molina, E Nicolas Rocamora, AI Bendicho, EG Vázquez, ... PloS one 17 (2), e0263140, 2022 | 69 | 2022 |
| Isogenic pairs of hiPSC-CMs with hypertrophic cardiomyopathy/LVNC-associated ACTC1 E99K mutation unveil differential functional deficits JGW Smith, T Owen, JR Bhagwan, D Mosqueira, E Scott, I Mannhardt, ... Stem cell reports 11 (5), 1226-1243, 2018 | 69 | 2018 |
| Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator A Protonotarios, R Bariani, C Cappelletto, M Pavlou, A García-García, ... European heart journal 43 (32), 3053-3067, 2022 | 66 | 2022 |
| Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention JM de la Hera, E Delgado, E Hernandez, JM García-Ruiz, JM Vegas, ... European heart journal 30 (21), 2614-2621, 2009 | 62 | 2009 |
| Aficamten for symptomatic obstructive hypertrophic cardiomyopathy MS Maron, A Masri, ME Nassif, R Barriales-Villa, M Arad, N Cardim, ... New England Journal of Medicine 390 (20), 1849-1861, 2024 | 61 | 2024 |
| Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation F Dominguez, V Climent, E Zorio, T Ripoll-Vera, J Salazar-Mendiguchia, ... International Journal of Cardiology 248, 232-238, 2017 | 61 | 2017 |
